Drug Shortage Report for FOQUEST

Last updated on 2022-05-05 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2022-06-30
Actual end date
Shortage status Actual shortage
Updated date 2022-05-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2022-05-05 French Compare
v16 2022-05-05 English Compare
v15 2022-04-07 French Compare
v14 2022-04-07 English Compare
v13 2022-02-25 French Compare
v12 2022-02-25 English Compare
v11 2022-02-11 French Compare
v10 2022-02-11 English Compare
v9 2022-01-26 French Compare
v8 2022-01-26 English Compare
v7 2022-01-06 English Compare
v6 2022-01-05 French Compare
v5 2022-01-05 English Compare
v4 2021-12-22 French Compare
v3 2021-12-22 English Compare
v2 2021-12-22 French Compare
v1 2021-12-22 English Compare

Showing 1 to 17 of 17